Copyright Reports & Markets. All rights reserved.

Global and Point of Care Testing for Infectious Disease Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis
    • 1.2.1 Global Point of Care Testing for Infectious Disease Market Size Growth Rate : 2020 VS 2026
    • 1.2.2 Immunological Test
    • 1.2.3 Pathogen Nucleic Acid Test
  • 1.3 Market by Application
    • 1.3.1 Global Point of Care Testing for Infectious Disease Market Share 7: 2020 VS 2026
    • 1.3.2 Hospital
    • 1.3.3 Clinics
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Point of Care Testing for Infectious Disease Market Perspective (2015-2026)
  • 2.2 Global Point of Care Testing for Infectious Disease Growth Trends by Regions
    • 2.2.1 Point of Care Testing for Infectious Disease Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Point of Care Testing for Infectious Disease Historic Market Share by Regions (2015-2020)
    • 2.2.3 Point of Care Testing for Infectious Disease Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Point of Care Testing for Infectious Disease Players by Market Size
    • 3.1.1 Global Top Point of Care Testing for Infectious Disease Players by Revenue (2015-2020)
    • 3.1.2 Global Point of Care Testing for Infectious Disease Revenue Market Share by Players (2015-2020)
  • 3.2 Global Point of Care Testing for Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Point of Care Testing for Infectious Disease Revenue
  • 3.4 Global Point of Care Testing for Infectious Disease Market Concentration Ratio
    • 3.4.1 Global Point of Care Testing for Infectious Disease Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Point of Care Testing for Infectious Disease Revenue in 2019
  • 3.5 Key Players Point of Care Testing for Infectious Disease Area Served
  • 3.6 Key Players Point of Care Testing for Infectious Disease Product Solution and Service
  • 3.7 Date of Enter into Point of Care Testing for Infectious Disease Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Point of Care Testing for Infectious Disease Breakdown Data (2015-2026)

  • 4.1 Global Point of Care Testing for Infectious Disease Historic Market Size (2015-2020)
  • 4.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size (2021-2026)

5 Point of Care Testing for Infectious Disease Breakdown Data 7 (2015-2026)

  • 5.1 Global Point of Care Testing for Infectious Disease Historic Market Size 7 (2015-2020)
  • 5.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size 7 (2021-2026)

6 North America

  • 6.1 North America Point of Care Testing for Infectious Disease Market Size (2015-2026)
  • 6.2 North America Point of Care Testing for Infectious Disease Market Size (2015-2020)
  • 6.3 North America Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)
  • 6.4 North America Point of Care Testing for Infectious Disease Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Point of Care Testing for Infectious Disease Market Size (2015-2026)
  • 7.2 Europe Point of Care Testing for Infectious Disease Market Size (2015-2020)
  • 7.3 Europe Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)
  • 7.4 Europe Point of Care Testing for Infectious Disease Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Point of Care Testing for Infectious Disease Market Size (2015-2026)
  • 8.2 China Point of Care Testing for Infectious Disease Market Size (2015-2020)
  • 8.3 China Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)
  • 8.4 China Point of Care Testing for Infectious Disease Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Point of Care Testing for Infectious Disease Market Size (2015-2026)
  • 9.2 Japan Point of Care Testing for Infectious Disease Market Size (2015-2020)
  • 9.3 Japan Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)
  • 9.4 Japan Point of Care Testing for Infectious Disease Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Point of Care Testing for Infectious Disease Market Size (2015-2026)
  • 10.2 Southeast Asia Point of Care Testing for Infectious Disease Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Point of Care Testing for Infectious Disease Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Point of Care Testing for Infectious Disease Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Abbott
    • 11.1.1 Abbott Company Details
    • 11.1.2 Abbott Business Overview
    • 11.1.3 Abbott Point of Care Testing for Infectious Disease Introduction
    • 11.1.4 Abbott Revenue in Point of Care Testing for Infectious Disease Business (2015-2020))
    • 11.1.5 Abbott Recent Development
  • 11.2 Roche
    • 11.2.1 Roche Company Details
    • 11.2.2 Roche Business Overview
    • 11.2.3 Roche Point of Care Testing for Infectious Disease Introduction
    • 11.2.4 Roche Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 11.2.5 Roche Recent Development
  • 11.3 Siemens
    • 11.3.1 Siemens Company Details
    • 11.3.2 Siemens Business Overview
    • 11.3.3 Siemens Point of Care Testing for Infectious Disease Introduction
    • 11.3.4 Siemens Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 11.3.5 Siemens Recent Development
  • 11.4 Danaher
    • 11.4.1 Danaher Company Details
    • 11.4.2 Danaher Business Overview
    • 11.4.3 Danaher Point of Care Testing for Infectious Disease Introduction
    • 11.4.4 Danaher Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 11.4.5 Danaher Recent Development
  • 11.5 Becton, Dickinson
    • 11.5.1 Becton, Dickinson Company Details
    • 11.5.2 Becton, Dickinson Business Overview
    • 11.5.3 Becton, Dickinson Point of Care Testing for Infectious Disease Introduction
    • 11.5.4 Becton, Dickinson Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 11.5.5 Becton, Dickinson Recent Development
  • 11.6 Johnson & Johnson
    • 11.6.1 Johnson & Johnson Company Details
    • 11.6.2 Johnson & Johnson Business Overview
    • 11.6.3 Johnson & Johnson Point of Care Testing for Infectious Disease Introduction
    • 11.6.4 Johnson & Johnson Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 11.6.5 Johnson & Johnson Recent Development
  • 11.7 Instrumentation Laboratory
    • 11.7.1 Instrumentation Laboratory Company Details
    • 11.7.2 Instrumentation Laboratory Business Overview
    • 11.7.3 Instrumentation Laboratory Point of Care Testing for Infectious Disease Introduction
    • 11.7.4 Instrumentation Laboratory Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 11.7.5 Instrumentation Laboratory Recent Development
  • 11.8 PTS Diagnostics
    • 11.8.1 PTS Diagnostics Company Details
    • 11.8.2 PTS Diagnostics Business Overview
    • 11.8.3 PTS Diagnostics Point of Care Testing for Infectious Disease Introduction
    • 11.8.4 PTS Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 11.8.5 PTS Diagnostics Recent Development
  • 11.9 Quidel
    • 11.9.1 Quidel Company Details
    • 11.9.2 Quidel Business Overview
    • 11.9.3 Quidel Point of Care Testing for Infectious Disease Introduction
    • 11.9.4 Quidel Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 11.9.5 Quidel Recent Development
  • 11.10 Sekisui Diagnostics
    • 11.10.1 Sekisui Diagnostics Company Details
    • 11.10.2 Sekisui Diagnostics Business Overview
    • 11.10.3 Sekisui Diagnostics Point of Care Testing for Infectious Disease Introduction
    • 11.10.4 Sekisui Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 11.10.5 Sekisui Diagnostics Recent Development
  • 11.11 Nova
    • 10.11.1 Nova Company Details
    • 10.11.2 Nova Business Overview
    • 10.11.3 Nova Point of Care Testing for Infectious Disease Introduction
    • 10.11.4 Nova Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 10.11.5 Nova Recent Development
  • 11.12 EKF Diagnostics
    • 10.12.1 EKF Diagnostics Company Details
    • 10.12.2 EKF Diagnostics Business Overview
    • 10.12.3 EKF Diagnostics Point of Care Testing for Infectious Disease Introduction
    • 10.12.4 EKF Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 10.12.5 EKF Diagnostics Recent Development
  • 11.13 AccuBioTech
    • 10.13.1 AccuBioTech Company Details
    • 10.13.2 AccuBioTech Business Overview
    • 10.13.3 AccuBioTech Point of Care Testing for Infectious Disease Introduction
    • 10.13.4 AccuBioTech Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 10.13.5 AccuBioTech Recent Development
  • 11.14 Trinity Biotech
    • 10.14.1 Trinity Biotech Company Details
    • 10.14.2 Trinity Biotech Business Overview
    • 10.14.3 Trinity Biotech Point of Care Testing for Infectious Disease Introduction
    • 10.14.4 Trinity Biotech Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
    • 10.14.5 Trinity Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Point of Care Testing for Infectious Disease Scope and Market Size
    Point of Care Testing for Infectious Disease market is segmented , and 7. Players, stakeholders, and other participants in the global Point of Care Testing for Infectious Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast and 7 in terms of revenue and forecast for the period 2015-2026.

    Market segment , the product can be split into
    Immunological Test
    Pathogen Nucleic Acid Test

    Market segment 7, split into
    Hospital
    Clinics
    Others

    Based on regional and country-level analysis, the Point of Care Testing for Infectious Disease market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Point of Care Testing for Infectious Disease market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbott
    Roche
    Siemens
    Danaher
    Becton, Dickinson
    Johnson & Johnson
    Instrumentation Laboratory
    PTS Diagnostics
    Quidel
    Sekisui Diagnostics
    Nova
    EKF Diagnostics
    AccuBioTech
    Trinity Biotech

    Buy now